EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended
		Mar. 31, 2017	Mar. 31, 2016
Net loss		$ (11,274)	$ (40,694)
Net loss attributable to noncontrolling interests		209	259
Preferred share accretion paid in kind		(2,357)	(4,510)
Net Income (Loss) Available to Common Stockholders, Basic		(13,422)	(44,945)
Net loss attributable to CME Ltd. available to common shareholders — diluted		$ (13,422)	$ (44,945)
Weighted average outstanding shares of common stock - basic (in shares)	[1]	154,795,000	147,078,000
Dilutive effect of employee stock options and RSUs (in shares)		0	0
Weighted average outstanding shares of common stock - diluted (in shares)		154,795,000	147,078,000
Net loss per share:
Net loss attributable to CME Ltd. – Basic		$ (0.09)	$ (0.31)
Net loss attributable to CME Ltd. – Diluted		$ (0.09)	$ (0.31)
Antidilutive securities excluded from computation of earnings per share		108,844,869	3,122,121
Series B Preferred Stock [Member]
Dilutive Securities, Effect on Basic Earnings Per Share		$ 0	$ 0
Common Class A [Member] | T W Investor [Member]
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock		11,211,449	11,211,449

[1] (1) For the purpose of computing basic earnings per share, the 11,211,449 shares of Class A common stock underlying the Series A Preferred Share are included in the weighted average outstanding shares of common stock - basic, because the holder of the Series A Preferred Share is entitled to receive any dividends payable when dividends are declared by the Board of Directors with respect to any shares of common stock.